Globus Medical Inc [clinicaltrials_resource:000755fbc8de0ad2e30ed4161910c839]
A Pivotal Study of a Facet Replacement System to Treat Spinal Stenosis [clinicaltrials:NCT00401518]SECURE®-C Cervical Artificial Disc Clinical Study/ SECURE-C Cervical Artificial Disc Postmarket Approval Study [clinicaltrials:NCT00882661]Study Evaluating the Safety and Effectiveness of the FLEXUS(TM) Interspinous Spacer [clinicaltrials:NCT01156675]TRIUMPH Lumbar Artificial Disc IDE: A Pilot Study [clinicaltrials:NCT01198470]clinicaltrials:NCT01441999clinicaltrials:NCT01861899Efficacy and Safety of Expandable Spacer in the Treatment of Degenerative Disc Disease Using the Minimally Invasive Transforaminal Lumbar Interbody Fusion Surgical Approach [clinicaltrials:NCT02075554]A Prospective Randomized Postmarket Clinical Study of the TRANSITION Stabilization System [clinicaltrials:NCT02184520]INDEPENDENCE Spacer for Lumbar Fusion [clinicaltrials:NCT02299323]A Retrospective Study Using CALIBER® TLIF Expandable Spacer in the Treatment of DDD: 2 Year Follow-up. [clinicaltrials:NCT02388022]
lead sponsor [clinicaltrials_vocabulary:lead-sponsor]
A Pivotal Study of a Facet Replacement System to Treat Spinal Stenosis [clinicaltrials:NCT00401518]SECURE®-C Cervical Artificial Disc Clinical Study/ SECURE-C Cervical Artificial Disc Postmarket Approval Study [clinicaltrials:NCT00882661]Study Evaluating the Safety and Effectiveness of the FLEXUS(TM) Interspinous Spacer [clinicaltrials:NCT01156675]TRIUMPH Lumbar Artificial Disc IDE: A Pilot Study [clinicaltrials:NCT01198470]clinicaltrials:NCT01441999clinicaltrials:NCT01861899Efficacy and Safety of Expandable Spacer in the Treatment of Degenerative Disc Disease Using the Minimally Invasive Transforaminal Lumbar Interbody Fusion Surgical Approach [clinicaltrials:NCT02075554]A Prospective Randomized Postmarket Clinical Study of the TRANSITION Stabilization System [clinicaltrials:NCT02184520]INDEPENDENCE Spacer for Lumbar Fusion [clinicaltrials:NCT02299323]A Retrospective Study Using CALIBER® TLIF Expandable Spacer in the Treatment of DDD: 2 Year Follow-up. [clinicaltrials:NCT02388022]
source [clinicaltrials_vocabulary:source]
Globus Medical Inc [clinicaltrials_resource:000755fbc8de0ad2e30ed4161910c839]
Bio2RDF identifier
000755fbc8de0ad2e30ed4161910c839
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:000755fbc8de0ad2e30ed4161910c839
organization [clinicaltrials_vocabulary:organization]
identifier
clinicaltrials_resource:000755fbc8de0ad2e30ed4161910c839
title
Globus Medical Inc
@en
type
label
Globus Medical Inc [clinicaltrials_resource:000755fbc8de0ad2e30ed4161910c839]
@en